Literature DB >> 12147000

Radioguidance is not necessary during parathyroidectomy.

William B Inabnet1, Chun K Kim, Richard S Haber, Richard A Lopchinsky.   

Abstract

BACKGROUND: Improvements in the accuracy of preoperative localization and the availability of the rapid parathyroid hormone assay have permitted minimally invasive parathyroidectomy in patients with primary hyperparathyoidism. HYPOTHESIS: The use of intraoperative radioguidance is beneficial during targeted parathyroid operations.
DESIGN: A retrospective analysis of a prospective database of patients.
SETTING: Tertiary care referral center. PATIENTS: During a 2(1/2)-year period, 130 patients underwent minimally invasive, targeted parathyroidectomy with intraoperative monitoring of the parathyroid hormone level. Of these, 60 patients underwent radioguided parathyroidectomy. Prior to surgery, a solitary parathyroid adenoma was visualized on technetium Tc 99m sestamibi scintigraphy in all patients selected for radioguided parathyroidectomy. A gamma probe was used to guide the surgical dissection.
RESULTS: All patients were cured following radioguided parathyroidectomy. In 29 patients (48%), the probe provided confusing or inaccurate information; however, a unilateral neck exploration with excision of a parathyroid adenoma was successfully completed in each of these patients. Forty-three cases were completed under local anesthesia and 85% were discharged home on the same day of surgery. There was 1 temporary recurrent laryngeal nerve palsy.
CONCLUSION: In the era of improved preoperative localization and intraoperative parathyroid hormone monitoring, the routine use of radioguidance is not recommended during parathyroidectomy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147000     DOI: 10.1001/archsurg.137.8.967

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

1.  Fluorescence-guided minimally invasive parathyroidectomy: a novel detection technique for parathyroid glands.

Authors:  R L Prosst; F Willeke; L Schroeter; S Post; J Gahlen
Journal:  Surg Endosc       Date:  2006-05-26       Impact factor: 4.584

2.  A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable?

Authors:  Herbert Chen; Eberhard Mack; James R Starling
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

3.  Radioguided parathyroidectomy for tertiary hyperparathyroidism.

Authors:  Yash R Somnay; Eric Weinlander; Amal Alfhefdi; David Schneider; Rebecca S Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2015-02-19       Impact factor: 2.192

Review 4.  Intraoperative adjuncts in surgery for primary hyperparathyroidism.

Authors:  Barney J Harrison; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

5.  Surgery for sporadic primary hyperparathyroidism: controversies and evidence-based approach.

Authors:  Antonio Sitges-Serra; Prieto Rosa; Mónica Valero; Estela Membrilla; Joan J Sancho
Journal:  Langenbecks Arch Surg       Date:  2008-02-21       Impact factor: 3.445

6.  Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands.

Authors:  Herbert Chen; Eberhard Mack; James R Starling
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

7.  Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism?

Authors:  Linwah Yip; Daniel A Pryma; John H Yim; Mohamed A Virji; Sally E Carty; Jennifer B Ogilvie
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

Review 8.  Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations.

Authors:  Radu Mihai; Marcin Barczynski; Maurizio Iacobone; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2009-06-25       Impact factor: 3.445

9.  2009 EANM parathyroid guidelines.

Authors:  Elif Hindié; Omer Ugur; David Fuster; Michael O'Doherty; Gaia Grassetto; Pablo Ureña; Andrew Kettle; Seza A Gulec; Francesca Pons; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-07       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.